Yet, both rodent and non-human primate studies suggest that IFN-α and IFN-ß treatment can confer partial protection from infection, reducing viremia and prolonging survival [19–21], suggesting that it may be possible to override the inhibitory effects of the virus by treatment with IFN. Here, IFNA1 is linked to infection.